BALAXI2024-04-012024-06-30 BALAXI2024-04-012024-06-30in-bse-fin:OneOperatingExpenses01Member BALAXI2024-06-30 iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 000000 BALAXI NOTLISTED BALAXI PHARMACEUTICALS LIMITED Equity 2024-04-01 2025-03-31 2024-08-02 2024-07-25 INR Lakhs First quarter 11:30:00 13:00:00 2024-08-02 2024-08-02 Not applicable Single segment Specialized Wholesale 2024-04-01 2024-06-30 Unaudited Consolidated 656215000.00 -18479000.00 637736000.00 381367000.00 0.00 0.00 81029000.00 3708000.00 4921000.00 92962000.00 563987000.00 73749000.00 0.00 73749000.00 9138000.00 -193000.00 8945000.00 0.00 64804000.00 0.00 0.00 0.00 0.00 64804000.00 0.00 64804000.00 0.00 0.00 0.00 0.00 110415000.00 2 1.17 1.17 0.00 0.00 1.17 1.17 0.00 0.00 0.00 1. The Un-Audited Consolidated Financial Results for the Quarter ended 30tht June , 2024 have been reviewed by the Audit Committee and approved by the Board of Directors at its meeting held on 2nd August, 2024. The Consolidated Financial Results are prepared in accordance with the Indian Accounting Standards (Ind AS) as prescribed under Section 133 of the Companies Act, 2013. 2. Previous period figures have been regrouped, re-arranged and re-classified wherever necessary to conform to current period’s classification.   3. The operating segment of the Group is identified as Specialized Wholesale as the Chief Operating Decision Maker reviews business performance at an overall level as one segment. Therefore, the disclosure as per Regulation 33 (1)(e ) read with Clause L of Schedule IV of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 is not applicable to the Company. Administrative Expenses 92962000.00 0.00 0.00